Industrial chicken is raised with routine antibiotics, and antibiotic-resistant bacteria (e.g., ESBL E. coli, MRSA, resistant Campylobacter, mcr-1) spread from poultry to humans via the food chain.
Original statement
فهو مُربّى بالمضادات الحيوية وأدوية الزرنيخ ... ويحمل بكتيريا متعددة المقاومة تنتقل إلى الإنسان عبر السلسلة الغذائية
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
Industrial chicken is raised with routine antibiotics, and antibiotic-resistant bacteria (e.g., ESBL E. coli, MRSA, resistant Campylobacter, mcr-1) spread from poultry to humans via the food chain.
Origin
- Source status
- Archive editors
- Attribution
- Archive editors (not Elawady)
- Origin
- https://eltayebat.com/rule/industrial-chicken/
- Attribution uncertainty
- Narrative and study selection written by the archive operators; the archive states the forbidden section is documented independently of Dr. Diaa's words.
- Claimed mechanism
Routine/sub-therapeutic antibiotic use selects resistant bacteria that reach humans via meat.
- Claimed health effect
Infections with resistant bacteria; loss of last-resort antibiotics.
- Population concerned
general population (not specified)
- Geographic restriction by Elawady
none found
Diverging source versions
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live! الالتهاب ايه هوه ؟ (Open source)
- Published
- 26 September 2025
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- البكتيريا النافعة ؟! Bacterial Flora , What do we know about it ？ (Open source)
- Published
- 11 January 2025
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- ودي الحلقه التانيه من البودكاست…حلقه استثنائيه وقولولي رأيكوا (Open source)
- Published
- 10 April 2026
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.
Scientific assessment
Mostly true – Correct at its core, but with limitations or minor inaccuracies.
Certainty of evidence: moderate – Further research may still affect the assessment.
1. What was claimed?
Chickens are raised on routine antibiotics and pass multidrug-resistant bacteria to humans.
2. What is demonstrably correct?
Global livestock antibiotic use was estimated at 63,151 tons (2010), projected +67% by 2030, with 148 mg/kg for chicken (model estimate). Dutch data: 94% of retail chicken samples contained ESBL producers; ESBL genes/plasmids indistinguishable from poultry types were found in human clinical isolates. mcr-1 was found in Chinese animals (21%), raw meat (15%) and inpatients (1%). The US withdrew fluoroquinolones from poultry in 2005 because of resistant Campylobacter. Restricting antibiotic use lowers resistance in animals (absolute reductions commonly 10-15%) and was associated with 24% lower prevalence in humans (stronger for people with animal contact).
3. What is wrong or exaggerated?
'Routine antibiotics' is not a uniform reality: the EU banned antibiotics as growth promoters from 1 January 2006 (Regulation 1831/2003); therapeutic use continues. Some cited studies concern pork (A-CHK-14) or US/China only. In the US retail-meat study, the headline 52% multidrug resistance pools all meats: chicken isolates had the lowest multidrug-resistance rate (26%, 6/23), no MRSA was found on chicken, and the authors state that the public-health relevance is unclear; the study has no human outcomes (A-CHK-01). The MRSA study in pork found no difference between conventional and 'raised without antibiotics' pork. Evidence for human population effects is smaller than for animals.
4. What remains unclear?
The share of human resistant infections attributable to poultry consumption versus human antibiotic use.
5. Which studies support it?
A-CHK-01 (resistant S. aureus on US retail meat; chicken-specific rates lower; no transmission data), A-CHK-02, A-CHK-03, A-CHK-05, A-CHK-07, A-CHK-08, A-CHK-11, A-CHK-15, A-CHK-17, A-CHK-19, I-CHK-01, I-CHK-04, I-CHK-13.
6. Which studies contradict it?
A-CHK-14 (no difference conventional vs antibiotic-free pork for MRSA).
7. What applies to Germany and Europe?
EU: growth promoters banned since 2006; harmonised AMR monitoring shows resistance varies greatly by country, with encouraging downward trends in key indicators in several Member States over 7 years (I-CHK-04). Increasing resistance to critically important antimicrobials in poultry-associated Salmonella and Campylobacter from humans was observed in at least half of reporting countries.
8. What is known about Egypt?
Egyptian broiler studies report high multidrug resistance in Salmonella (76.7% of isolates in one province, I-CHK-09), frequent antibiotic residues above MRLs in chicken tissues (I-CHK-12), and colistin resistance (I-CHK-13). This suggests the concern is more relevant for Egypt than for the EU, but national surveillance data were not reviewed.
9. What practical conclusion is appropriate?
Antibiotic resistance via poultry is a real One Health problem; it is addressed through prudent use, regulation and kitchen hygiene (resistant bacteria are killed by cooking like others).
Assessment details
- Rationale for certainty of evidence
Consistent microbiological and molecular evidence (shared ESBL genes/plasmids/strains in Dutch chicken and patients; mcr-1 in Chinese animals, meat and patients; FQ-resistant Campylobacter linked to poultry) plus a systematic review showing that restricting antibiotic use lowers resistance in animals and, with less evidence, in humans. Population-level attribution of human infections to poultry is less certain.
- Source quality
Archive editorial with accurately cited, mostly high-quality studies; some (MRSA in pork, A-CHK-14) concern pork, not chicken.
- Regional transferability
Highly dependent on country: EU banned antibiotic growth promoters from 2006 and monitors resistance; resistance is lower in some EU countries and decreasing in several. Egypt has reported high multidrug resistance in poultry Salmonella and colistin resistance (I-CHK-09, I-CHK-13).
- Individual exceptions
Risk is higher for people with direct animal contact (farmers, slaughterhouse workers).
- Regional scope of the claim
- depends on production conditions
- Last reviewed
- 25 October 2026 provisional
In plain language
The archive says chickens are given many antibiotics and that resistant bacteria can pass from chicken to people. This is largely supported: Dutch studies found the same resistance genes in chicken meat and in patients, and countries that limited antibiotics in animals saw less resistance. The European Union has banned antibiotics as growth boosters since 2006, while studies from Egypt show high levels of resistance and drug residues in chicken. Proper cooking and kitchen hygiene reduce the risk for consumers.
Studies on this claim
Studies supporting the claim (14)
-
Resistant Staphylococcus on US meat
Waters AE et al.. Clin Infect Dis 2011 · PMID 21498385 · DOI 10.1093/cid/cir181Cross-sectional studycited by the Tayebat archivefull text checked★ key studyAlmost half of meat samples carried S. aureus; about half of the isolates were multidrug-resistant, but for chicken it was about a quarter and no MRSA was found on chicken.
Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
What are the prevalence, resistance and genotypes of S. aureus in US meat and poultry?
- How was the study done?
Cross-sectional microbiological survey of retail meat and poultry with susceptibility testing and genotyping
- How many people, animals or samples were studied?
136 samples; Retail meat and poultry samples
- What was actually found?
S. aureus: turkey 77%, pork 42%, chicken 41%, beef 37%; multidrug resistance 52% overall (chicken 26%); MRSA 3 isolates, none from chicken.
- How large was the observed effect?
Proportions; comparisons between sample types
- What do the results mean in everyday life?
Raw meat can carry resistant bacteria; hygiene and cooking matter.
- What are the study's limitations?
Small convenience sample; mixed meats; no human outcomes; funded by an advocacy foundation; authors say public-health relevance is unclear.
- What does it say about Elawady's specific claim?
Supports presence of resistant bacteria on meat.
- Do the results apply to Germany and Europe?
Moderate; EU AMR monitoring covers MRSA.
- What can explicitly not be concluded from this study?
Cannot show how many people get sick.
-
Same resistance genes in Dutch chicken and patients
Leverstein-van Hall MA et al.. Clin Microbiol Infect 2011 · PMID 21463397 · DOI 10.1111/j.1469-0691.2011.03497.xCross-sectional studycited by the Tayebat archiveabstract only checked★ key studyMost retail chicken had ESBL bacteria, and many human isolates shared the same genes and plasmids.
Does the study support the specific claim? Yes · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
What proportion of human clinical ESBL E. coli carry poultry-associated genes, plasmids and strains?
- How was the study done?
Molecular epidemiological study comparing ESBL genes, plasmids and strains from poultry, retail chicken and human clinical isolates
- How many people, animals or samples were studied?
98 retail chicken samples; 516 human clinical samples; Retail chicken, poultry, human clinical samples from 31 labs
- What was actually found?
94% of retail meat samples contained ESBL producers; 39% of these belonged to E. coli genotypes also present in human samples. 35% of human isolates contained poultry-associated ESBL genes; 19% had PA genes on IncI1 plasmids indistinguishable from poultry.
- How large was the observed effect?
Descriptive proportions; microarray, pMLST, MLST
- What do the results mean in everyday life?
Resistance genes can move from poultry to people.
- What are the study's limitations?
Cross-sectional; direction of transmission inferred; 2009 data
- What does it say about Elawady's specific claim?
Supports the claim.
- Do the results apply to Germany and Europe?
High (EU country).
- What can explicitly not be concluded from this study?
Cannot say how many human infections come from chicken.
-
ESBL genes in Dutch chicken meat and people
Overdevest I et al.. Emerg Infect Dis 2011 · PMID 21762575 · DOI 10.3201/eid1707.110209Cross-sectional studycited by the Tayebat archiveabstract only checkedFour in five chicken samples had ESBL genes, matching those found in people.
Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
What are prevalence and characteristics of ESBL genes in retail chicken and humans in the Netherlands?
- How was the study done?
Cross-sectional study of ESBL genes in retail chicken and human rectal/blood isolates
- How many people, animals or samples were studied?
Not stated in abstract; Retail chicken; patients in 4 hospitals
- What was actually found?
ESBL genes in 79.8% of chicken meat; predominant genes identical in meat and human rectal swabs; frequently in blood isolates; high similarity of E. coli strains.
- How large was the observed effect?
Descriptive
- What do the results mean in everyday life?
Resistant bacteria on raw chicken are common in some countries.
- What are the study's limitations?
Directionality inferred; Sample sizes not in abstract
- What does it say about Elawady's specific claim?
Supports the claim.
- Do the results apply to Germany and Europe?
High.
- What can explicitly not be concluded from this study?
Cannot prove transmission direction.
-
Global antibiotic use in farm animals
Van Boeckel TP et al.. Proc Natl Acad Sci U S A 2015 · PMID 25792457 · DOI 10.1073/pnas.1503141112Othercited by the Tayebat archiveabstract only checked★ key studyModels estimated about 63,000 tons used in 2010 with a projected 67% increase by 2030.
Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
How much antimicrobial is used in livestock globally and how will it change?
- How was the study done?
Bayesian modelling of global antimicrobial use in food animals for 2010 and 2030
- How many people, animals or samples were studied?
Not applicable; Global livestock (cattle, chicken, pigs)
- What was actually found?
Average 45 (cattle), 148 (chicken), 172 (pigs) mg/kg. Increase of 67% from 63,151 +/- 1,560 t to 105,596 +/- 3,605 t (2010-2030). Up to a third of increase from middle-income countries shifting to intensive systems; BRICS +99%.
- How large was the observed effect?
Bayesian models
- What do the results mean in everyday life?
Antibiotic use in farming is large and growing in middle-income countries.
- What are the study's limitations?
Extrapolation from high-income data; Model uncertainty larger than reported SD may suggest
- What does it say about Elawady's specific claim?
Supports the context of the claim.
- Do the results apply to Germany and Europe?
Moderate.
- What can explicitly not be concluded from this study?
Cannot show use in a given country.
-
Resistant Campylobacter linked to poultry in the US
Kassenborg HD et al.. Clin Infect Dis 2004 · PMID 15095200 · DOI 10.1086/381597Case-control studycited by the Tayebat archiveabstract only checkedDomestic resistant infections were linked to eating chicken or turkey at restaurants.
Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
What are risk factors for fluoroquinolone-resistant Campylobacter infection?
- How was the study done?
Population-based case-control study (FoodNet)
- How many people, animals or samples were studied?
858 isolates tested; 64 FQ-resistant vs 582 susceptible with travel data; 33 matched case-control pairs; Patients with Campylobacter infection and matched controls
- What was actually found?
11% resistant. Travel OR 7.6 (4.3-13.4). Domestic cases: eating chicken or turkey at commercial establishment matched OR 10.0 (1.3-78).
- How large was the observed effect?
OR, matched OR
- What do the results mean in everyday life?
Poultry can transmit resistant Campylobacter.
- What are the study's limitations?
Very wide CI (only 33 pairs); Recall bias
- What does it say about Elawady's specific claim?
Supports.
- Do the results apply to Germany and Europe?
Moderate.
- What can explicitly not be concluded from this study?
Precise risk size.
-
US ban of fluoroquinolones in poultry
Nelson JM et al.. Clin Infect Dis 2007 · PMID 17342653 · DOI 10.1086/512369Narrative reviewcited by the Tayebat archiveabstract only checkedResistance concerns led the US to withdraw enrofloxacin from poultry in 2005.
Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
What happened after fluoroquinolones were withdrawn from US poultry?
- How was the study done?
Review of FQ-resistant Campylobacter and US regulatory withdrawal of enrofloxacin in poultry
- How many people, animals or samples were studied?
Not applicable; US
- What was actually found?
FDA proposed withdrawal in 2000; enrofloxacin withdrawn from poultry effective September 2005; resistant strains continue to circulate.
- How large was the observed effect?
Not applicable
- What do the results mean in everyday life?
Regulators can restrict drugs that drive resistance.
- What are the study's limitations?
Narrative; Authors from US agencies
- What does it say about Elawady's specific claim?
Supports problem existence.
- Do the results apply to Germany and Europe?
Moderate.
- What can explicitly not be concluded from this study?
Cannot quantify impact.
-
Discovery of transferable colistin resistance (mcr-1) in China
Liu YY et al.. Lancet Infect Dis 2016 · PMID 26603172 · DOI 10.1016/S1473-3099(15)00424-7Othercited by the Tayebat archiveabstract only checked★ key studyA transferable gene making bacteria resistant to the last-resort antibiotic colistin was found in animals, meat and some patients.
Does the study support the specific claim? Yes · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Is there plasmid-mediated polymyxin resistance in Enterobacteriaceae in China?
- How was the study done?
Surveillance plus microbiological and molecular study discovering plasmid-mediated colistin resistance (mcr-1)
- How many people, animals or samples were studied?
804 animals; 523 raw meat samples; 1,322 inpatient samples; E. coli and K. pneumoniae from food animals, raw meat and inpatients in five provinces
- What was actually found?
mcr-1 in 166/804 (21%) animals, 78/523 (15%) raw meat, 16/1322 (1%) inpatients; transferable by conjugation; negated colistin in mice.
- How large was the observed effect?
Descriptive; conjugation frequencies; mouse model
- What do the results mean in everyday life?
Farm antibiotic use can threaten important human medicines.
- What are the study's limitations?
China-specific surveillance; Index strain from a pig; poultry-specific share not given in abstract
- What does it say about Elawady's specific claim?
Supports resistance concern.
- Do the results apply to Germany and Europe?
Moderate.
- What can explicitly not be concluded from this study?
Not specific to chicken.
-
Less resistance on farms that stopped antibiotics
Sapkota AR et al.. Environ Health Perspect 2011 · PMID 21827979 · DOI 10.1289/ehp.1003350Cross-sectional studycited by the Tayebat archiveabstract only checkedPoultry houses that switched to organic had far fewer multidrug-resistant bacteria.
Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Does transition to organic practices lower antibiotic-resistant Enterococcus on poultry farms?
- How was the study done?
Field comparison of resistant Enterococcus in conventional vs newly organic poultry houses
- How many people, animals or samples were studied?
20 houses; 259 Enterococcus isolates; 10 conventional and 10 newly organic poultry houses
- What was actually found?
MDR E. faecalis 42% conventional vs 10% organic (p=0.02); MDR E. faecium 84% vs 17% (p<0.001).
- How large was the observed effect?
GLMM
- What do the results mean in everyday life?
Reducing antibiotic use reduces resistance.
- What are the study's limitations?
Small number of houses; Farm environment, not meat
- What does it say about Elawady's specific claim?
Supports.
- Do the results apply to Germany and Europe?
Moderate.
- What can explicitly not be concluded from this study?
Cannot show human health effect.
-
US Salmonella outbreak from one chicken company
Gieraltowski L et al.. PLoS One 2016 · PMID 27631492 · DOI 10.1371/journal.pone.0162369Outbreak reportcited by the Tayebat archivefull text checked634 people fell ill from resistant Salmonella traced to one company's chicken.
Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
What caused a large multistate MDR Salmonella Heidelberg outbreak?
- How was the study done?
Outbreak investigation (epidemiological, laboratory, traceback)
- How many people, animals or samples were studied?
634 cases; 435 interviewed; 634 US case-patients
- What was actually found?
634 sick (38% hospitalised, no deaths); 87% of those with brand data ate Company A chicken; 67% of tested patient isolates resistant, 35% multidrug-resistant; Salmonella in 26% of samples at the implicated plants, down to about 5% after fixes.
- How large was the observed effect?
Descriptive
- What do the results mean in everyday life?
Shows why safe handling of raw chicken matters.
- What are the study's limitations?
Single outbreak
- What does it say about Elawady's specific claim?
Supports existence of hazard.
- Do the results apply to Germany and Europe?
Moderate.
- What can explicitly not be concluded from this study?
Cannot give routine prevalence in chicken and does not support an 80-85% contamination rate.
-
Urinary infection E. coli genes in Danish chicken and pork
Jakobsen L et al.. Int J Food Microbiol 2010 · PMID 20656368 · DOI 10.1016/j.ijfoodmicro.2010.06.025Cross-sectional studycited by the Tayebat archiveabstract only checkedE. coli from meat had virulence genes similar to those from patients with urinary infections.
Does the study support the specific claim? Yes · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Could broiler meat and pork be sources of ExPEC strains in humans?
- How was the study done?
Molecular comparison of ExPEC virulence genes in E. coli from UTI patients, community humans, meat and animals
- How many people, animals or samples were studied?
964 isolates; 964 E. coli isolates
- What was actually found?
Seven of eight ExPEC-related genes detected in isolates from broiler meat, broilers, pork and pigs; strong similarities between human and meat/animal isolate profiles.
- How large was the observed effect?
PCR; cluster analysis
- What do the results mean in everyday life?
Meat could be one source of bacteria causing urinary infections.
- What are the study's limitations?
Gene presence, not transmission proof
- What does it say about Elawady's specific claim?
Supports plausibility.
- Do the results apply to Germany and Europe?
High.
- What can explicitly not be concluded from this study?
Cannot prove transmission.
-
Less antibiotics in farm animals, less resistance
Tang KL et al.. Lancet Planet Health 2017 · PMID 29387833 · DOI 10.1016/S2542-5196(17)30141-9Meta-analysisindependent cross-checkfull text checked★ key studyRestricting antibiotics in livestock reduced resistant bacteria in animals and, in fewer studies, in people.
Does the study support the specific claim? Yes · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Effect of restricting antibiotic use in food animals on resistance in animals and humans
- How was the study done?
Systematic review and meta-analysis (WHO-commissioned)
- How many people, animals or samples were studied?
181 studies (179 animal, 21 human); Food-producing animals; humans
- What was actually found?
In animals resistance was usually 10-15 percentage points lower with restrictions (poultry 18 points); in studied humans 24 points lower, mainly in farm workers (29 points) and much less in non-farm people (9 points, 3 studies).
- How large was the observed effect?
Random-effects risk differences
- What do the results mean in everyday life?
Prudent farm antibiotic use protects human medicine.
- What are the study's limitations?
Mostly cross-sectional, poorly adjusted studies; very high heterogeneity; few human studies, mostly farm workers; possible publication bias in human studies; almost no data from low- and middle-income countries.
- What does it say about Elawady's specific claim?
Supports.
- Do the results apply to Germany and Europe?
High.
- What can explicitly not be concluded from this study?
Cannot quantify effect on all consumers.
-
EU report on antibiotic resistance in food animals
EFSA, ECDC. EFSA J 2024 · PMID 38419967 · DOI 10.2903/j.efsa.2024.8583Otherindependent cross-checkabstract only checkedResistance in poultry-linked bacteria is common and varies by country, but key indicators improved in several countries.
Does the study support the specific claim? Yes · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
AMR in Salmonella, Campylobacter, indicator E. coli, MRSA in humans, animals, food
- How was the study done?
EU harmonised AMR monitoring report
- How many people, animals or samples were studied?
Not stated in abstract; EU MSs
- What was actually found?
Resistance differed greatly between countries; resistance to common antimicrobials frequent in Salmonella and Campylobacter; increasing resistance to a critically important antimicrobial in poultry-associated Salmonella and Campylobacter from humans in at least half of reporting countries; encouraging progress in key outcome indicators in several MSs over 7 years.
- How large was the observed effect?
Descriptive; trend analysis
- What do the results mean in everyday life?
The problem is real in the EU too, but monitored.
- What are the study's limitations?
Country variation in sampling
- What does it say about Elawady's specific claim?
Supports, with nuance.
- Do the results apply to Germany and Europe?
Directly EU.
- What can explicitly not be concluded from this study?
Not consumer risk per meal.
-
Salmonella in Egyptian broiler chickens
Elkenany R et al.. BMC Vet Res 2019 · PMID 31029108 · DOI 10.1186/s12917-019-1867-zCross-sectional studyindependent cross-checkfull text checkedAbout 29% of retail chicken carcasses and 32% of farm chickens in one Egyptian province had Salmonella, mostly multidrug-resistant.
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Prevalence, resistance and virulence genes of Salmonella in broilers and retail carcasses
- How was the study done?
Cross-sectional microbiological survey
- How many people, animals or samples were studied?
420 samples from 5 broiler farms and 5 retail shops, El-Sharkia, summer 2017
- What was actually found?
Salmonella in 28.6% of all samples (carcasses 29.4%, cloacal swabs 32%, environment 22%); 76.7% of isolates multidrug-resistant; all resistant to trimethoprim-sulfamethoxazole; none to imipenem.
- How large was the observed effect?
Descriptive
- What do the results mean in everyday life?
In Egypt, careful handling and cooking of chicken is especially important.
- What are the study's limitations?
Only 5 farms and 5 shops in one province, one season; no human data; descriptive only.
- What does it say about Elawady's specific claim?
Supports concern but not 80-85%.
- Do the results apply to Germany and Europe?
Low (Egypt).
- What can explicitly not be concluded from this study?
Not national.
-
Colistin resistance in the Middle East and North Africa
Saniour R et al.. Microorganisms 2026 · PMID 42655038 · DOI 10.3390/microorganisms14081693Narrative reviewindependent cross-checkabstract only checkedResistance to the last-resort antibiotic colistin is reported in Egypt and other countries, including in poultry.
Does the study support the specific claim? Yes · Methodological quality: low · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Epidemiology of colistin resistance in MENA
- How was the study done?
Narrative review
- How many people, animals or samples were studied?
Not applicable; Humans, animals, food, environment
- What was actually found?
North Africa prevalence of colistin-resistant Gram-negatives: Tunisia 58.09%, Egypt 24.76%, Algeria 14.29%, Libya 2.86% (from available literature); mcr-1 predominant; resistance documented in poultry and food.
- How large was the observed effect?
Descriptive
- What do the results mean in everyday life?
Farm antibiotic use matters for human medicine in Egypt too.
- What are the study's limitations?
Narrative; heterogeneous sources
- What does it say about Elawady's specific claim?
Supports.
- Do the results apply to Germany and Europe?
Low.
- What can explicitly not be concluded from this study?
Not precise prevalence.
No study in this group is marked as key.
Studies contradicting or limiting the claim (2)
-
MRSA in US retail pork
O'Brien AM et al.. PLoS One 2012 · PMID 22276147 · DOI 10.1371/journal.pone.0030092Cross-sectional studycited by the Tayebat archiveabstract only checkedPork raised without antibiotics carried MRSA as often as conventional pork.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
What is S. aureus/MRSA prevalence in conventional vs alternative retail pork?
- How was the study done?
Cross-sectional retail survey of S. aureus and MRSA in pork
- How many people, animals or samples were studied?
395 pork samples; Retail pork from 36 stores
- What was actually found?
S. aureus 64.8%; MRSA 6.6% (4.3-9.5%); no significant differences between conventional and alternative pork.
- How large was the observed effect?
Proportions, 95% CI
- What do the results mean in everyday life?
Not about chicken.
- What are the study's limitations?
Pork, not poultry
- What does it say about Elawady's specific claim?
Limits the claim.
- Do the results apply to Germany and Europe?
Moderate.
- What can explicitly not be concluded from this study?
Says nothing about chicken.
-
EU ban on antibiotic growth promoters
European Parliament and Council. Official Journal of the EU (copy at legislation.gov.uk) 2003Guideline / position statementindependent cross-checkfull text checkedSince 2006, antibiotics may not be used as growth-promoting feed additives in the EU.
Does the study support the specific claim? No · Methodological quality: not applicable · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Rules for feed additives including phase-out of antibiotic growth promoters
- How was the study done?
EU regulation
- How many people, animals or samples were studied?
Not applicable; EU animal feed
- What was actually found?
Article 11(2): antibiotics, other than coccidiostats and histomonostats, may be marketed and used as feed additives only until 31 December 2005; from 1 January 2006 deleted from the Register. Recital 25 cites the Scientific Steering Committee: growth-promoting antimicrobials from classes used in medicine should be phased out.
- How large was the observed effect?
Not applicable
- What do the results mean in everyday life?
"Routine antibiotics for growth" is not legal in the EU.
- What are the study's limitations?
Therapeutic and prophylactic veterinary use regulated separately (not covered)
- What does it say about Elawady's specific claim?
Limits the claim for the EU.
- Do the results apply to Germany and Europe?
Directly EU.
- What can explicitly not be concluded from this study?
Does not cover therapeutic use.
No study in this group is marked as key.
Studies with mixed or unclear results (1)
-
Antibiotic residues in Egyptian chicken
Noah SM et al.. Sci Rep 2026 · PMID 42527435 · DOI 10.1038/s41598-026-63227-2Measurement / residue studyindependent cross-checkfull text checked★ key studyMany chicken samples had antibiotic residues above legal limits, especially in liver, but estimated health risk was low.
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Antibiotic residues in chicken tissues and consumer risk
- How was the study done?
Cross-sectional residue survey (HPLC) with risk assessment
- How many people, animals or samples were studied?
180 samples (60 breast, 60 thigh, 60 liver); Chicken tissues from poultry shops
- What was actually found?
Detected: enrofloxacin 51.67%, oxytetracycline 71.67%, sulfadimidine 16.67%; of positives, 54.84%, 55.81% and 70% exceeded MRLs. Liver had highest levels (e.g., oxytetracycline mean 10,625 ug/kg). EDI 0.012-0.590 ug/kg bw/day; HQ 0.0002-0.050, indicating no significant health risk.
- How large was the observed effect?
Descriptive; HQ
- What do the results mean in everyday life?
Withdrawal periods are not always respected in some Egyptian supply chains.
- What are the study's limitations?
One city; unclear shop selection; no confirmatory LC-MS/MS; risk estimate uses average levels and intakes only; eggs not studied.
- What does it say about Elawady's specific claim?
Supports residue concern in Egypt; not toxicity.
- Do the results apply to Germany and Europe?
Low (Egypt).
- What can explicitly not be concluded from this study?
Cannot generalise nationwide.
No study in this group is marked as key.
Regional context
Germany / EU
EU: growth promoters banned since 2006; harmonised AMR monitoring shows resistance varies greatly by country, with encouraging downward trends in key indicators in several Member States over 7 years (I-CHK-04). Increasing resistance to critically important antimicrobials in poultry-associated Salmonella and Campylobacter from humans was observed in at least half of reporting countries.
Egypt
Egyptian broiler studies report high multidrug resistance in Salmonella (76.7% of isolates in one province, I-CHK-09), frequent antibiotic residues above MRLs in chicken tissues (I-CHK-12), and colistin resistance (I-CHK-13). This suggests the concern is more relevant for Egypt than for the EU, but national surveillance data were not reviewed.
- Food-safety governance and official controls
- Pesticide residues in fruit and vegetables on the EU/German market (incl. imports from Egypt)
- Pesticide residues in produce sold on the Egyptian domestic market
- Antibiotic (veterinary drug) residues in poultry meat and eggs
- Antimicrobial use in food animals and antibiotic growth promoters
- Hormones in poultry, meat, milk and farmed fish
- Salmonella in laying hens, eggs and broiler chicken
- Dioxins, PCBs and PFAS in eggs and other animal foods
- Aflatoxin M1 in milk and dairy products
- Aflatoxins in groundnuts (peanuts)
- Heavy metals in fish
- Farmed fish (aquaculture): drugs, water source and controls
- Import controls and the meaning of RASFF notifications for Egyptian products
What applies in my country?
General scientific assessment
Mostly true Antibiotic use in poultry does contribute to resistant bacteria reaching humans; the size of the problem depends strongly on the country.
The following areas of food safety are relevant to this statement:
- Pesticides and pesticide residues
- Veterinary medicines and antibiotics
- Hormonal growth promoters
- Contaminants (heavy metals, PFAS, PCBs, dioxins, nitrate)
- Pathogens (Salmonella, Campylobacter, etc.)
- Animal husbandry and feed
- Controls, imports, recalls, labelling
Eggs · Poultry · Dairy · Fish and seafood · Red meat · Fruit and vegetables
Choose a country to see the checked information for it.
Limits: legal rules describe what is allowed, not what every single food contains. Measurement data come from samples and are meaningful only together with their method details.
Country of residence or purchase Compare with another country
References
- Multidrug-Resistant Staphylococcus aureus in US Meat and Poultry.. Waters AE et al.. Clin Infect Dis 2011 · PMID 21498385 · DOI 10.1093/cid/cir181
- Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains.. Leverstein-van Hall MA et al.. Clin Microbiol Infect 2011 · PMID 21463397 · DOI 10.1111/j.1469-0691.2011.03497.x
- Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands.. Overdevest I et al.. Emerg Infect Dis 2011 · PMID 21762575 · DOI 10.3201/eid1707.110209
- Global trends in antimicrobial use in food animals.. Van Boeckel TP et al.. Proc Natl Acad Sci U S A 2015 · PMID 25792457 · DOI 10.1073/pnas.1503141112
- Fluoroquinolone-resistant Campylobacter infections: eating poultry outside of the home and foreign travel are risk factors.. Kassenborg HD et al.. Clin Infect Dis 2004 · PMID 15095200 · DOI 10.1086/381597
- Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story.. Nelson JM et al.. Clin Infect Dis 2007 · PMID 17342653 · DOI 10.1086/512369
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study.. Liu YY et al.. Lancet Infect Dis 2016 · PMID 26603172 · DOI 10.1016/S1473-3099(15)00424-7
- Lower prevalence of antibiotic-resistant Enterococci on U.S. conventional poultry farms that transitioned to organic practices.. Sapkota AR et al.. Environ Health Perspect 2011 · PMID 21827979 · DOI 10.1289/ehp.1003350
- National Outbreak of Multidrug Resistant Salmonella Heidelberg Infections Linked to a Single Poultry Company.. Gieraltowski L et al.. PLoS One 2016 · PMID 27631492 · DOI 10.1371/journal.pone.0162369
- Broiler chickens, broiler chicken meat, pigs and pork as sources of ExPEC related virulence genes and resistance in Escherichia coli isolates from community-dwelling humans and UTI patients.. Jakobsen L et al.. Int J Food Microbiol 2010 · PMID 20656368 · DOI 10.1016/j.ijfoodmicro.2010.06.025
- Restricting the use of antibiotics in food-producing animals and its associations with antibiotic resistance in food-producing animals and human beings: a systematic review and meta-analysis.. Tang KL et al.. Lancet Planet Health 2017 · PMID 29387833 · DOI 10.1016/S2542-5196(17)30141-9
- The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2021-2022.. EFSA, ECDC. EFSA J 2024 · PMID 38419967 · DOI 10.2903/j.efsa.2024.8583
- Antimicrobial resistance profiles and virulence genotyping of Salmonella enterica serovars recovered from broiler chickens and chicken carcasses in Egypt.. Elkenany R et al.. BMC Vet Res 2019 · PMID 31029108 · DOI 10.1186/s12917-019-1867-z
- Overview of Colistin Resistance in the Middle East and North Africa (MENA) Region.. Saniour R et al.. Microorganisms 2026 · PMID 42655038 · DOI 10.3390/microorganisms14081693
- MRSA in conventional and alternative retail pork products.. O'Brien AM et al.. PLoS One 2012 · PMID 22276147 · DOI 10.1371/journal.pone.0030092
- Regulation (EC) No 1831/2003 on additives for use in animal nutrition (original text, Article 11 and recitals 25-26). European Parliament and Council. Official Journal of the EU (copy at legislation.gov.uk) 2003
- Health risk assessment of enrofloxacin, oxytetracycline, and sulfadimidine residues in broiler chicken carcasses marketed in Mit Ghamr, Egypt.. Noah SM et al.. Sci Rep 2026 · PMID 42527435 · DOI 10.1038/s41598-026-63227-2